Abstract | BACKGROUND: METHODS: RESULTS: Only gonorrhea cases were significantly more likely to have a large hsCRP rise (≥1.40 mg/L or ≥239%) during infection than controls (P < 0.01). However, gonorrhea, IM, and other systemic/non-genitourinary cases were more likely to have a rise of any magnitude up to one year post-diagnosis than controls (p = 0.038-0.077). CONCLUSIONS: These findings, which differ from those for PSA, suggest distinct mechanisms of elevation for hsCRP and PSA, and support both direct (eg, prostate infection) and indirect (eg, systemic inflammation-mediated prostate cell damage) mechanisms for PSA elevation. Future studies should explore our PSA findings further for their relevance to both prostate cancer screening and risk.
|
Authors | Melissa Milbrandt, Anke C Winter, Remington L Nevin, Ratna Pakpahan, Gary Bradwin, Angelo M De Marzo, Debra J Elliott, Charlotte A Gaydos, William B Isaacs, William G Nelson, Nader Rifai, Lori J Sokoll, Jonathan M Zenilman, Elizabeth A Platz, Siobhan Sutcliffe |
Journal | The Prostate
(Prostate)
Vol. 77
Issue 13
Pg. 1325-1334
(May 2017)
ISSN: 1097-0045 [Electronic] United States |
PMID | 28703328
(Publication Type: Journal Article)
|
Copyright | © 2017 Wiley Periodicals, Inc. |
Chemical References |
- C-Reactive Protein
- Prostate-Specific Antigen
|
Topics |
- Adult
- C-Reactive Protein
(analysis)
- Chlamydia Infections
(blood)
- Gonorrhea
(blood)
- Humans
- Infectious Mononucleosis
(blood)
- Male
- Middle Aged
- Prostate-Specific Antigen
(analysis)
- Prostatitis
(blood, diagnosis, etiology)
- Statistics as Topic
- Urethritis
(blood, diagnosis, etiology)
|